One-carbon Therapeutics to Present Trial-in-Progress Poster on ODIN Phase 1/2 Study ofTH9619 at the 2026 ASCO Annual Meeting
Solna, Sweden, May 29th, 2026. One-carbon Therapeutics AB, a clinical-stage
Follow our progress as we advance TH9619 through clinical development
Solna, Sweden, May 29th, 2026. One-carbon Therapeutics AB, a clinical-stage
Solna, Sweden, May 21, 2026. One-carbon Therapeutics AB, a clinical-stage
Solna, Sweden, March 17h, 2026. One-carbon Therapeutics, a clinical-stage oncology
Solna, Sweden, December 1, 2025. One-carbon Therapeutics AB, a clinical-stage
Stockholm, Sweden. November 17th, 2025. One-carbon Therapeutics AB, a clinical-stage biotechnology
One-carbon therapeutics AB is discussing the ODIN trial with several
Read the article here.
In preparation and expansion for the upcoming clinical trial, we
Professor Johann de Bono, Head of the Division of Clinical